RetinAI Expands Operations with a U.S. Office In Boston and Achieves 21 CFR Part 11 Compliance to Support Research and Clinical Studies
RetinAI Expands Operations with a U.S. Office In Boston and Achieves 21 CFR Part 11 Compliance to Support Research and Clinical Studies Bern, Switzerland, and Boston, USA September 28, 2022 – RetinAI Medical AG (“RetinAI”), is a leader in clinical and imaging data management software and adva...